Dow Up 0.04% Nasdaq Down 0.17%

Navidea Biopharmaceuticals, Inc (NAVB)

-NYSE MKT
1.28 Up 0.01(0.79%) 10:34AM EDT - Nasdaq Real Time Price
Prev Close:1.27
Open:1.25
Bid:1.26 x 1500
Ask:1.28 x 2700
1y Target Est:4.05
Beta:0.92
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:1.25 - 1.28
52wk Range:1.11 - 3.15
Volume:36,711
Avg Vol (3m):887,558
Market Cap:192.21M
P/E (ttm):N/A
EPS (ttm):-0.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NAVB

Comparison

Symbol% ChgMkt Cap
NAVBUp 0.79%192.21M
LLYDown 0.08%66.56B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):69.05
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.27
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback